Mindmaze : One of Switzerland’s Best Managed Companies
read article Visit Website
Mindmaze : Is the Nasdaq an option for growth ?
According to the article in the newspaper AGEFI, Mindmaze is considering an IPO that could help its growth, but the main goal remains the development of products to help people wit
MindMaze announces that MindMotion GO has been cleared for the US market from the Food and Drug Administration !
Following 2017 FDA approval of the MindMotion PRO, MindMaze is now the first company to have FDA-approved products for inpatient as well as outpatient care. visit website read arti
« MindMaze, neurosciences’ first Unicorn is Swiss ».
$909 Mio were invested in startups in Switzerland in 2016. MindMaze is one of them! Tadi has brought Switzerland into the small club of countries able to produce a « unicorn »
MINDMAZE the Lausanne-based start-up would be worth 1 billion dollars.
visit website read article